Icon Advisers Has Upped Cdk Global (CDK) Position by $5.85 Million as Market Valuation Declined; As Celgene (CELG) Valuation Declined, Shareholder Edinburgh Partners LTD Has Upped Its Position

CDK Global, Inc. (NASDAQ:CDK) Logo

Icon Advisers Inc increased its stake in Cdk Global Inc (CDK) by 61.38% based on its latest 2017Q4 regulatory filing with the SEC. Icon Advisers Inc bought 82,428 shares as the company’s stock declined 11.91% with the market. The institutional investor held 216,728 shares of the miscellaneous company at the end of 2017Q4, valued at $15.45 million, up from 134,300 at the end of the previous reported quarter. Icon Advisers Inc who had been investing in Cdk Global Inc for a number of months, seems to be bullish on the $8.64B market cap company. The stock increased 1.50% or $0.97 during the last trading session, reaching $65.67. About 1.28 million shares traded or 3.86% up from the average. CDK Global, Inc. (NASDAQ:CDK) has declined 2.80% since April 30, 2017 and is downtrending. It has underperformed by 14.35% the S&P500.

Sandy Nairn increased its stake in Celgene Corp (CELG) by 16.96% based on its latest 2017Q4 regulatory filing with the SEC. Edinburgh Partners Ltd bought 45,801 shares as the company’s stock declined 19.30% with the market. The hedge fund run by Sandy Nairn held 315,906 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $32.97M, up from 270,105 at the end of the previous reported quarter. Edinburgh Partners Ltd who had been investing in Celgene Corp for a number of months, seems to be bullish on the $68.58 billion market cap company. The stock decreased 0.98% or $0.9 during the last trading session, reaching $91.18. About 4.21 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 30, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Icon Advisers Inc, which manages about $2.21B and $1.45B US Long portfolio, decreased its stake in Ameren Corp. (NYSE:AEE) by 11,900 shares to 26,900 shares, valued at $1.59 million in 2017Q4, according to the filing. It also reduced its holding in Wheaton Precious Metals Corp by 65,000 shares in the quarter, leaving it with 40,000 shares, and cut its stake in Facebook Inc. Class A (NASDAQ:FB).

Among 8 analysts covering CDK Global (NASDAQ:CDK), 4 have Buy rating, 0 Sell and 4 Hold. Therefore 50% are positive. CDK Global had 16 analyst reports since August 14, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, January 31. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, February 3. The stock of CDK Global, Inc. (NASDAQ:CDK) earned “Equal-Weight” rating by Morgan Stanley on Friday, April 27. The company was upgraded on Thursday, February 4 by Barrington Research. The rating was upgraded by JP Morgan on Wednesday, April 6 to “Neutral”. The company was downgraded on Wednesday, January 17 by Barrington Research. The firm earned “Buy” rating on Wednesday, January 31 by Wells Fargo. Wells Fargo upgraded the shares of CDK in report on Wednesday, June 21 to “Outperform” rating. The rating was maintained by Oppenheimer with “Buy” on Wednesday, August 9. JP Morgan maintained the stock with “Underweight” rating in Tuesday, December 15 report.

Edinburgh Partners Ltd, which manages about $378.76M US Long portfolio, decreased its stake in Perkinelmer Inc (NYSE:PKI) by 105,135 shares to 380,499 shares, valued at $27.83 million in 2017Q4, according to the filing. It also reduced its holding in Whirlpool Corp (NYSE:WHR) by 15,382 shares in the quarter, leaving it with 159,301 shares, and cut its stake in Cisco Systems Inc (NASDAQ:CSCO).

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.34, from 1.17 in 2017Q3. It turned negative, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Chemical Bank reported 21,932 shares stake. California-based Btr Mgmt has invested 0.04% in Celgene Corporation (NASDAQ:CELG). Cambridge Rech Advsr Inc invested in 37,350 shares or 0.05% of the stock. Boltwood Management holds 0.32% or 4,985 shares. The Texas-based Cadence Bancorp Na has invested 0.25% in Celgene Corporation (NASDAQ:CELG). Schroder Inv Group stated it has 0.04% in Celgene Corporation (NASDAQ:CELG). Tributary Capital accumulated 0.04% or 4,600 shares. First Commonwealth Corporation Pa reported 0.74% stake. Alkeon Capital Ltd Limited Liability Company invested in 1.03 million shares. Rhumbline Advisers reported 1.23 million shares. 1.73M are owned by Healthcor Management Ltd Partnership. Braun Stacey accumulated 75,507 shares. Maple Capital Mgmt stated it has 6,344 shares or 0.17% of all its holdings. Ngam Advsrs Lp has invested 0.18% of its portfolio in Celgene Corporation (NASDAQ:CELG). Fernwood Invest Management Lc accumulated 3,975 shares.

Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 1 Sell and 14 Hold. Therefore 56% are positive. Celgene Corporation had 142 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Outperform” rating by Cowen & Co on Wednesday, August 12. On Thursday, July 27 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The stock of Celgene Corporation (NASDAQ:CELG) has “Underweight” rating given on Monday, October 23 by Morgan Stanley. The firm earned “Buy” rating on Thursday, January 7 by Suntrust Robinson. Canaccord Genuity maintained Celgene Corporation (NASDAQ:CELG) rating on Thursday, July 27. Canaccord Genuity has “Buy” rating and $15600 target. The company was initiated on Friday, February 5 by Leerink Swann. RBC Capital Markets maintained Celgene Corporation (NASDAQ:CELG) on Tuesday, January 23 with “Buy” rating. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Cowen & Co on Tuesday, September 12. The stock has “Buy” rating by SunTrust on Monday, January 8. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Monday, October 16 by Canaccord Genuity.

Since February 8, 2018, it had 1 insider purchase, and 3 sales for $3.58 million activity. $851,093 worth of Celgene Corporation (NASDAQ:CELG) shares were sold by LOUGHLIN JAMES J. Another trade for 18,500 shares valued at $1.77M was sold by KAPLAN GILLA. Alles Mark J also bought $299,594 worth of Celgene Corporation (NASDAQ:CELG) shares.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart